Michael Scolaro

Michael Scolaro

Aug 28, 2017

Group 6 Copy 194
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    A Prescription for Health and Fitness Based on Your Genes

    Exercise has many health benefits. Yet, most people stop their exercise programs after they start them. What...

    A Modification to Homeopathic Drug Carcinosin

    Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem completely...

    Backer Badge Funded